Cited by — Integrative Multiomics Profiling Reveals Immune Determinants of Response to Disitamab Vedotin Plus Penpulimab in HER2‐Low Breast Cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Integrative Multiomics Profiling Reveals Immune Determinants of Response to Disitamab Vedotin Plus Penpulimab in HER2‐Low Breast Cancer.
No admitted local citation edges point to this work yet.
